SENSEX
NIFTY
GOLD
USD/INR

Weather

image 30    C

Economy News

The Economic Times

Economy / The Economic Times

details

Dr Reddys aims to resume semaglutide supply by November after API fix

Dr Reddy's expects to resume semaglutide supplies by November after resolving quality issues. The company identified the root cause and plans corrective measures by September. Financial results were impacted by a provision linked to the semaglutide active pharmaceutical ingredient. Despite disruptions, Dr Reddy's maintains its growth and profitability guidance for fiscal year 2027. The drugmaker anticipates supplying millions of semaglutide units this fiscal year.

22 Jul 2026 11:17 pm